AACR Highlights Cancer Research Initiatives at its 101st Annual Meeting 2010 in Washington, D.C.
WASHINGTON, D.C. — The American Association for Cancer Research will gather at the nation’s capitol next week for its Annual Meeting, and key cancer research issues will be on the agenda for more than 17,000 attendees.
All sessions are open to the media. Reporters and editors should contact the Annual Meeting press office to obtain complimentary registration and credentials.
AACR Releases Tobacco Statement
Last year, the AACR formed its Task Force on Tobacco and Cancer to provide information and resources for policy makers to combat a preventable carcinogen that causes cancer at 18 different organ sites and is responsible for 30 percent of all cancer deaths in the United States.
Earlier this week, the task force released its official policy statement in Cancer Research, a journal of the American Association for Cancer Research. The statement will be further discussed at the Annual Meeting on Tuesday, April 20, from 4 p.m. to 5:30 p.m. ET in room 201 of the Walter E. Washington Convention Center. View the program to learn more.
AACR Leaders to Discuss Institute of Medicine Report on Clinical Trials
The Institute of Medicine released recommendations to improve the efficacy of clinical trial design. This report concerns consolidation and efficiency, applying the most advanced science, funding and support, and methods to increase participation among patients and physicians.
The report will be discussed at the Annual Meeting on Monday, April 19, from 2 p.m. to 3 p.m. ET in Salon C, East Hall, of the Walter E. Washington Convention Center. View the program to learn more.
NIH Director to Speak at Annual Meeting
The AACR is honored to have Francis Collins, M.D., Ph.D., director of the National Institutes of Health (NIH), address the Annual Meeting on Monday, April 19, at 3 p.m. ET in Ballroom A-B of the Walter E. Washington Convention Center.
Collins is a physician-geneticist noted for his landmark discoveries of disease genes and his leadership of the Human Genome Project, which culminated in April 2003 with the completion of the mapping and sequencing of human DNA.
NCI Director to Address Annual Meeting
In what is regularly a highlight of the Annual Meeting, National Cancer Institute (NCI) Director John E. Niederhuber, M.D., will update the Annual Meeting attendees on NCI’s efforts to ensure a promising future of cancer research innovation and discovery.
Niederhuber will speak on Monday, April 19, at 11:15 a.m. ET in room 206 of the Walter E. Washington Convention Center.
AACR to Assess State of Federal Investment in Cancer Research
Thanks to the revitalization of research stimulated by the American Recovery and Reinvestment Act of 2009, countless promising research projects are now underway. With adequate and sustained federal investment in the NIH and NCI, cancer researchers will be able to fully capitalize on the expanded research capacity and advances that have been accelerated over the last year.
On Monday, April 19, from 5 p.m. to 6 p.m. ET, the AACR will host a panel discussion on cancer research funding issues that will focus on the current budgetary environment and ways the research community can influence the legislative process. Particular attention will be paid to maximizing our investment to fulfill President Obama’s vision of curing cancer in our time.
The discussion will take place in room 206 of the Walter E. Washington Convention Center.
AACR to Discuss What Health Care Reform Means for the Future of Cancer Research
In addition to expanding access and improving health care for millions, the recently enacted health care reform legislation addresses specific priorities for the cancer research community and opens the door to new opportunities.
On Tuesday, April 20, from 10:30 a.m. to noon ET in room 206 of the Walter E. Washington Convention Center, a distinguished panel of experts will discuss the impact of health care reform on cancer research and the clinical research enterprise, covering issues of comparative effectiveness research (CER), health information technology and personalized medicine.
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes 31,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowship and career development awards. The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes six major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists. CR provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship and advocacy.
In Washington, D.C.
April 17-21: (202) 249-4098